Results 171 to 180 of about 958,101 (344)
At least five related, but distinct, hepatitis C viral genotypes exist. [PDF]
T A+6 more
openalex +1 more source
This study presents a binary tumor‐microenvironment‐on‐a‐chip (T‐MOC) system incorporating multicellular tumor spheroids (MCTs) as an alternative preclinical platform to evaluate the efficacy of anticancer natural products. The T‐MOC model reproduces in vivo drug delivery barriers and physiological conditions, enabling morphological analysis to predict
Youngwon Kim+7 more
wiley +1 more source
Degree of Viremia and Liver Histology in Chronic Hepatitis C
Md Atiqur Rahman, Sultana Rokeya Mannan
openalex +2 more sources
Status of Health related Quality of life between HBV and HCV Patients of Pakistan [PDF]
The aim of the study is to explore the factors those differentiate health related quality of life (HRQOL) among hepatitis B (HBV) and hepatitis C (HCV) patients. Different public and private hospitals of Sargodha district were visited and 120 patients of
Ali, Mumtaz+3 more
core +1 more source
Current herpesvirus treatments targeting the viral DNA polymerase are limited by toxicities and drug resistance. Novel compounds inhibiting the nuclease activity of the herpes simplex virus 1 (HSV‐1) terminase complex, required for viral genome packaging, have been identified.
Sabina Andreu+12 more
wiley +1 more source
Clathrin Light Chain B (CLTB) drives hepatocellular carcinoma progression through dual pathways: intracellularly, it activates the NF‐κB–PCLAF axis to enhance small extracellular vesicle (sEV) uptake and tumor proliferation; extracellularly, CLTB‐enriched sEVs bind SH3KBP1 to inhibit its degradation, inducing angiogenesis and vascular leakage ...
Xiaoke Sun+7 more
wiley +1 more source
METABOLISM OF THE BLOOD INSULIN AND C-PEPTIDE IN ACUTE HEPATITIS
Shinobu Tanabashi+6 more
openalex +2 more sources
Interferon alfa for chronic hepatitis C in haemophiliacs. [PDF]
Michael Makris+5 more
openalex +1 more source
AI‐Assisted Drug Re‐Purposing for Human Liver Fibrosis
A multi‐agent AI (AI co‐scientist) is used to repurpose drugs for liver fibrosis treatment and to guide their experimental characterization. The anti‐fibrotic efficacy and toxicity of these drugs is assessed in multi‐lineage human hepatic organoids grown in microwells (microHOs).
Yuan Guan+20 more
wiley +1 more source